Spectrum of Infections in Renal Transplant

Slides:



Advertisements
Similar presentations
Risk Stratification in Renal Care Mary Jane McKendry Vice President, Operations Fresenius Disease Management Optimal Renal Care.
Advertisements

Network 11 Quality Update Chris Singer, MAN, RN, CNN December 4, 2008.
V.: 9/7/2007 AC Submit1 Statistical Review of the Observational Studies of Aprotinin Safety Part I: Methods, Mangano and Karkouti Studies CRDAC and DSaRM.
Recent management of Renal Transplantation in a Developing Country like Bangladesh, R Alam, Islam M S, R Alam, H Rahman, HU Rashid Department of Nephrology,
CAPD THE SAUDI EXPRIENCE THE SAUDI EXPRIENCE. Dialysis in Saudi Arabia There are 6700 patients on dialysis in Saudi Arabia There are 6700 patients on.
Dr. Charu Kartik Senior Clinical Dietitian KFSH&RC,Riyadh Dr. Charu Kartik Senior Clinical Dietitian KFSH&RC,Riyadh NUTRITIONAL CO-MORBITIES POST RENAL.
Peritoneal Dialysis for Elderly Patients: A Review Source: Tesar V. Peritoneal dialysis in the elderly—is its underutilization justified? Nephrol Dial.
ETHNIC DISPARITIES IN KIDNEY TRANSPLANTATION: REPLACEMENT OF RENAL FUNCTION IN ROMA („GYPSIE“) MINORITY IN CROATIA Milica Kljak University Hospital Centre.
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Years of Age Hiromichi Suzuki, Tsutomu Inoue,Tomohiro.
Experience with Calcineurin Inhibitor-Free Immunosuppression in Kidney Transplantation with Marginal Donors Oppenheimer F, Saval N, Gutierrez A, Cam pistol.
Incidence of hospitalisations in both groups Incidence of documented infections Abstract Problem statement: Patients on cancer chemotherapy are at substantial.
The Expanded Criteria Donors in Kidney Transplantation: 3 Years Experience FAM Shaheen, B. Al-Attar, MZ Souqiyyeh, J.E Cillo, A. Al Sayyari.
Arnold School of Public Health Health Services, Policy, and Management 1 Drug Treatment Disparities Among African Americans Living with HIV/AIDS Carleen.
M ORNING R EPORT February 17, R ENAL T RANSPLANTS Most frequent transplant 45% of all pediatric transplants 7% of renal transplants ≤ 17y 3 year.
Impact of Renal Transplantation on Psychosocial Status of HIV Positive Patients DR. Prof. D. K. AGARWAL MD,DM,DNB,MAMS,FICP,FISN Senior Consultant Nephrologist,
CR-1 Everolimus Benefit/Risk Assessment Howard J. Eisen, MD Thomas J. Vischer Professor of Medicine Chief, Division of Cardiology Drexel University College.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
LUNG TRANSPLANTATION Adult Recipients 2014 JHLT Oct; 33(10):
Long Term Complications in Renal Transplantation SALEH A.A BINSALEH.
Pre transplant nephrectomy , our experience in Prince Hussien Center of Urology and Organ transplantation By : Dr. Ghaith Gsous third year general surgery.
Dr Michelle Webb Renal Consultant, Associate Medical Director Patient Safety, East Kent Hospitals University NHS Foundation Trust and Co-lead for Sepsis.
Outline of the Presentation
INTRODUCTION South Africa has the highest reported incidence of tuberculosis (TB) globally at 860 cases per per year, and the third highest absolute.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
Risk Factors for Candida dubliniensis Bloodstream Infections Katherine Veltman, B.S., Peggy L. Carver, Pharm.D, FCCP The University of Michigan Health.
INTRODUCTION. The annual incidence of liver transplant outcomes in South America has been unknown. So far direct correlations have been reported between.
Preemptive Kidney Transplant (PKT) – the Optimal Therapy in ESRD Reference: Connie L. Davis. Preemptive transplantation and the transplant first initiative.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
Infection following KTP 신장내과 R3 김경엽. Infections Infections Leading cause of morbidity and mortality in the early posttransplant period Leading cause of.
Inflammatory Bowel Disease Is Associated With an Increased Incidence of Cardiovascular Events Andres J. Yarur, MD, Amar R. Deshpande, MD, David M. Pechman,
Statins The AURORA Trial Reference Fellstrom BC. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360. A.
KDIGO guidelines glomerulonephritis Dr.. Overview Rationale for requirement of guidelines KDIGO: GN Guidelines  Scope Clinical Nephrology Conferences.
Hypomagnesemia and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation J Am Soc Nephrol 27: 1793–1800, 2016 순천향 대학병원 신장내과 강혜란.
Hepatitis B virus infection in renal transplant recipients
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Section 1: CKD Epidemiology
Organ Failure in Nepal: Rapidly Growing Challenge for All
An AKI project for critically ill cancer patients
- Higher SBP visit-to-visit variability (SBV) has been associated
Nephrology Journal Club The SPRINT Trial Parker Gregg
The LIVES Sub-analysis
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Nitroxoline does not result in microbiological eradication in geriatric patients with lower urinary tract infection: a prospective cohort study C. Forstner1,2*,,
Proteinuria in a Renal transplant Recipient
Effects of Uric acid- lowering therapy on renal outcomes: a systematic review and meta-analysis Nephrol Dial Transplant (2014) 29: Vaughan Washco.
First-year death rates by modality figure 8
Improved long-term graft function and similar height changes with very low-dose steroid versus late steroid withdrawal in pediatric renal transplantation.
RENAL TRANSPLANTATION IN AN INTENSIVE CARE UNIT:
EFFICACY AND SAFETY OF ANTI-THYMOCYTE GLOBULIN (ATG) TREATMENT OF STEROID RESISTANT ACUTE REJECTION IN KIDNEY TRANSPLANTATION E. Bertoni, M. Biagini, M.
Vrushali Patwardhan, Dinesh Kumar, Varun Goel, Sarman Singh
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
UK Renal Registry 18th Annual Report
Risk of post-operative stroke in patients with known extra-cranial carotid artery disease undergoing Non-Cardiac Surgery Heart and Vascular.
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
Hospital admissions per patient, by modality figure 5
T. Rana, L. Szabo, A. Asderakis, E. Ablorsu
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Valley Fever (Coccidioidomycosis) Incidence of Valley Fever in the US.
Incidence or Prevalence, per 100,000 Burden, no. of cases per year*
HEPATOCELLULAR CARCINOMA (HCC) at
2018 Annual Data Report Volume 1: Chronic Kidney Disease
These slides highlight an educational report from a late-breaking clinical trials presentation at the 58th Annual Scientific Session of the American College.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
Tolerability of Isoniazid Preventive therapy Among HIV infected Cohort in Nigeria Folajinmi Oluwasina Strategic Information Unit AIDS Healthcare Foundation,
Cryptococcal Immune Reconstitution Inflammatory Syndrome
An Observational Study on Thrombotic Microangiopathy in Renal Transplant Recipients - A Tertiary Care Centre Experience. Dr Sarang Vijayan Senior Resident.
Cryptococcal Immune Reconstitution Inflammatory Syndrome
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Consultant Clinical Biochemist
Presentation transcript:

Spectrum of Infections in Renal Transplant Dr. Salil Jain Fortis Memorial Research Institute, Gurgaon

INTRODUCTION Transplantation Dialysis ESRD CKD CKD- an EPIDEMIC Prevalence- 1 in 10 Progressive disease ESRD 150,000- in India on waitlist for renal tx Renal tx- 1 out of 30 90%- on waiting list die without getting an organ Transplantation Dialysis ESRD CKD

COMPLICATIONS OF KIDNEY TRANSPLANT Rejection Infection Side effects of immunosupressants

Infections Rejection Immunosuppression

Infections Late presentation Endemic infections eg TB Expensive/nonavailability of lab tests Lack of awareness in primary care physicians Infections Socioeconomic status Poor hygiene New potent immunosupressives Tropical climate

Post Renal Tx -Infections Developed vs developing nations- different spectrum of infections Developing- 25% patients serious infection  allograft dysfunction Infections accounts for 50% deaths in India Common infections: UTI, TB, Candidiasis, Hepatitis B/C, CMV, Pneumocystis jirovecii

Aim & Objective To study the incidence of infections in post renal allograft recipient and influence of factors leading to infections To find out the most common cause of infections in post renal transplant patients To correlate the incidence of various infections with the literature

Materials and methods Single Centre observational retrospective hospital based study Inclusion Criteria: all of the following All patients who underwent renal transplant from September, 2013 to January, 2017 at FMRI Patients having regular follow up for at least 3 months post transplant in Outpatient clinic Exclusion criteria : Patients lost to follow up after first 3 months Definition of infection- culture/serology positive with suggestive symptoms

Results Baseline characteristics Variable n No of transplants 150 Males 124 Females 26 Mean age (years) 41.1 + 14.66 Dialysis vintage 7.38 months(15 days to 72 mnths) Primary diagnosis Hypertension Diabetes CGN Obstructive PKD CIN Unclassified 72 44 14 6 7 5 2

Results Baseline characteristics Variable n(%) Induction IL-2 50 (33.3%) ATG 91 (60.7%) No induction 9 (6%)

Patient distribution

Spectrum of positive cultures

Results- type of infection Infections Number of episodes UTI 48 GI infection 27 Pneumonia 11 Soft tissue infection 8 Fungal 3 TB 2 Parvovirus Herpes CMV

Spectrum of infection

Spectrum of bacterial infections E. coli 30(34%) Klebsiella 13(14.7%) Staphylococcus 10(11.3%) Pseudomonas 7(7.9%) Enterococcus Acinetobacter 4(4.5%)

Bacterial infections-spectrum

Infection Incidence of infection ATG 46% P = 0.69 IL-2 42.8% Diabetic 43.2% P= 0.98 Nondiabetic 43.3%

Kumar 2016 R Ram 2005 S Sujit 2016 FMRI No. of patients 45 169 50 150 Mean age (years) 35.5+10.4 34.1+11.4 - 41.1 Infection episodes After 1 year 57 77.7% 410 128 105 Induction, ATG vs IL-2 9.2 vs 6.8% NS UTI 33.3% 23.6% 72.7% 46.6% TB 17.8% 10.6% 1.9% Fungal 15.6% 23% 8% 2.9% CMV 13.3% 21.8% 7.8% HBV 11.1% 9.4% 3.9% HCV 7.6% Deaths 8.9% 2.4% 1.3% 10%

Discussion Overeall, infection incidence was lower compared to other studies in similar geographical region Lower rate of CMV due to universal prophylaxis Lower HBV/HCV due to stringent pretx workup and better medications for their tx. Fungal/CMV infections have come down considerably in last 10 years due to better prophylaxis and lesser immunosuppression.

Conclusion Infection still remains one of the most important complication and cause of mortality in transplant patients UTI continues to be the commonest post transplant infection We need investigations to monitor immune function to effectively manage immunosuppression Multicentric prospective studies needed to assess various factors associated with infection To increase the safety of organ transplantation further, we need improved diagnostic tests to detect infection earlier